Loading...

ANIK ANIKA THERAPEUTICS INC Management Changes 8-K Filing

NK T

NK

ANIKA THERAPEUTICS INC

(ANIK)

2026 8-K

Leadership Transition

Leadership Transition

Financial Update

Financial Statements

Product Expansion

Appointing directors

Financial Statements

Management Change

Financial Results

Q3 Financial Results

Earnings Reports

Annual Meeting of Stockholders

Cooperation Agreement and B...

Appointment of CFO

Earnings Reports

Earnings Reports

Retirement of Director

Earnings Reports

Investor Conferences

Earnings Reports

Amendment and Appointment

Earnings Reports

Settlement Agreement

Cooperation Agreement

External Links:

Anika Therapeutics announced on February 26, 2026, a Transition Agreement allowing Mr. Colleran to remain as Executive VP until May 1, 2026, with continued salary and benefits, while also announcing financial results for Q4 and the year ended December 31, 2025.

AI Assistant

ANIKA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.